Search

everythinglearnresearchcommunity

for

Search:↓

The document shows the state of pharmaceutical patents as of 1999, focusing on treatments for various diseases.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Testosterone's role in women's sex drive is unclear and needs more research, as low levels don't always mean less sexual interest and high levels can cause side effects.

A new method accurately detects bisphenols and parabens in human hair.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

ERULUS controls root hair growth by regulating cell wall composition and pectin activity.

Vitamin A affects hair loss and immune response in alopecia areata.

Creating fully functional artificial skin for chronic wounds is still very challenging.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

Root hair growth in plants is a complex process controlled by many factors working together.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

Menopause worsens skin, hair, and nails, affecting self-esteem and quality of life.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Testosterone injections can cause skin darkening and thickening.

Aspartic acid at 0.75% makes perms more effective and less damaging to hair.

The document concludes that non-binary individuals need compassionate support and recognition in healthcare, without being pathologized.

Niosomes are a promising, stable, and cost-effective drug delivery system with potential for improved targeting and safety.

Beard hair follicles have more androgen receptors than non-balding scalp hair follicles.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Oral contraceptives provide various health benefits beyond birth control, including managing menstrual issues, skin conditions, pain, and reducing the risk of certain cancers.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Non-motor symptoms in myasthenia gravis are common and need early diagnosis for better management.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

New genes found linked to balding, may help develop future treatments.